• 16.12.2019 – 13:17

  Cilian AG

  

  New in-vivo study confirms that ciliate vaccine protects against flu

  more

• 12.10.2019 – 10:45

  Daiichi Sankyo

  European Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA® (edoxaban)

  Munich (ots/PRNewswire) - - One-year outcomes of real-world edoxaban-treated European patients from the Global ETNA-AF registry showed low rates of potentially life-threatening bleeding and low CV events in elderly NVAF patients1 - The Global ETNA-AF programme is currently the largest and most comprehensive ...

  more

• 08.10.2018 – 16:18

  JTI Japan Tobacco International AG

  72% Say Policy-Making Should Be Open to Dialogue With Business: New European Research Commissioned by JTI Shows that Policies Based on Evidence and Dialogue Are Needed to Restore Public Trust in Policy-Making

  Geneva (ots/PRNewswire) - As the eighth session of the Conference of the Parties (COP8) to the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) just closed in Geneva, new research commissioned by JTI and conducted in Europe by Populus with Ipsos as fieldwork providers, reveals that the ...

  more

• 20.08.2018 – 16:00

  The Thrombosis Research Institute

  Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018

  Munich (ots/PRNewswire) - - Satellite symposium will highlight the breadth of evidence collected since the establishment of the registry in 2009 - An analysis of the comparative effectiveness of oral anticoagulants in everyday practice will be presented - The economic burden of atrial fibrillation (AF) in nine ...

  more